Literature DB >> 31163193

Parametric investigation of static and dynamic cell culture conditions and their impact on hCMEC/D3 barrier properties.

S Hinkel1, K Mattern2, A Dietzel2, S Reichl1, C C Müller-Goymann3.   

Abstract

In brain research, the hCMEC/D3 cell line is widely used for the establishment of a human in vitro blood-brain barrier (BBB) model. However, its barrier integrity seems to be insufficient for drug permeability studies, represented by rather low transendothelial electrical resistance (TEER) and high permeability of small molecules. Therefore, this study covers a parametric investigation of static and dynamic cell culture conditions to improve barrier functionality of hCMEC/D3. The effect of basal media was investigated by analyzing changes in proliferation rate, barrier integrity and gene expression of cellular junction proteins. The cells were able to grow in different cell culture media, including serum-free media. However, none of these media enhanced strongly the growth rate or barrier integrity compared to the microvascular endothelial cell growth medium-2 (EGM™-2 MV). Furthermore, hCMEC/D3 cells did not respond positively regarding TEER to any tested parameter neither supplements, coating materials nor co-cultures with the human immortalized astrocyte cell line SVGmm. Furthermore, the impact of dynamic conditions was examined by using the Dynamic Micro Tissue Engineering System (DynaMiTES). Cultivation conditions were successfully adapted to the DynaMiTES design and no negative effect was detected by analyzing cell viability and cell count, albeit TEER remained also unchanged. Consequently, the hCMEC/D3 model has considerable limitations and further improvements or alternative cell lines are required.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier (BBB) model; Cerebral DynaMiTES; Co-cultivation; Flow conditions; Permeability; hCMEC/D3

Mesh:

Year:  2019        PMID: 31163193     DOI: 10.1016/j.ijpharm.2019.05.074

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Measuring barrier function in organ-on-chips with cleanroom-free integration of multiplexable electrodes.

Authors:  Elsbeth G B M Bossink; Mariia Zakharova; Douwe S de Bruijn; Mathieu Odijk; Loes I Segerink
Journal:  Lab Chip       Date:  2021-05-18       Impact factor: 6.799

Review 2.  Review of Design Considerations for Brain-on-a-Chip Models.

Authors:  Tiffany Cameron; Tanya Bennet; Elyn M Rowe; Mehwish Anwer; Cheryl L Wellington; Karen C Cheung
Journal:  Micromachines (Basel)       Date:  2021-04-15       Impact factor: 2.891

3.  Tissue Barrier-on-Chip: A Technology for Reproducible Practice in Drug Testing.

Authors:  Eugen V Koch; Verena Ledwig; Sebastian Bendas; Stephan Reichl; Andreas Dietzel
Journal:  Pharmaceutics       Date:  2022-07-12       Impact factor: 6.525

4.  Microfluidic System for In Vivo-Like Drug Permeation Studies with Dynamic Dilution Profiles.

Authors:  Thomas Lorenz; Mona Kirschke; Verena Ledwig; Stephan Reichl; Andreas Dietzel
Journal:  Bioengineering (Basel)       Date:  2021-05-05

5.  Recent progress in translational engineered in vitro models of the central nervous system.

Authors:  Polyxeni Nikolakopoulou; Rossana Rauti; Dimitrios Voulgaris; Iftach Shlomy; Ben M Maoz; Anna Herland
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

6.  Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B0AT2 and y+LAT1 functional cooperation.

Authors:  Mehdi Taslimifar; Martin Faltys; Vartan Kurtcuoglu; François Verrey; Victoria Makrides
Journal:  J Cereb Blood Flow Metab       Date:  2021-08-24       Impact factor: 6.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.